These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9388203)

  • 1. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
    Eccles MR; Yun K; Reeve AE; Fidler AE
    Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired box gene expression in Wilms' tumor.
    Tagge EP; Hanson P; Re GG; Othersen HB; Smith CD; Garvin AJ
    J Pediatr Surg; 1994 Feb; 29(2):134-41. PubMed ID: 7909843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potential.
    Poleev A; Okladnova O; Musti AM; Schneider S; Royer-Pokora B; Plachov D
    Eur J Biochem; 1997 Aug; 247(3):860-9. PubMed ID: 9288908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
    Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors.
    Poleev A; Wendler F; Fickenscher H; Zannini MS; Yaginuma K; Abbott C; Plachov D
    Eur J Biochem; 1995 Mar; 228(3):899-911. PubMed ID: 7737192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter.
    Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF
    J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX8-mediated activation of the wt1 tumor suppressor gene.
    Dehbi M; Pelletier J
    EMBO J; 1996 Aug; 15(16):4297-306. PubMed ID: 8861958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
    Werner H; Roberts CT; Rauscher FJ; LeRoith D
    J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
    Martinerie C; Chevalier G; Rauscher FJ; Perbal B
    Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture.
    Scholz H; Bossone SA; Cohen HT; Akella U; Strauss WM; Sukhatme VP
    J Biol Chem; 1997 Dec; 272(52):32836-46. PubMed ID: 9407061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
    Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
    Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pax-2, kidney development, and oncogenesis.
    Dressler GR
    Med Pediatr Oncol; 1996 Nov; 27(5):440-4. PubMed ID: 8827071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of Pax-2 by WT1 during normal kidney development.
    Ryan G; Steele-Perkins V; Morris JF; Rauscher FJ; Dressler GR
    Development; 1995 Mar; 121(3):867-75. PubMed ID: 7720589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.
    Discenza MT; Dehbi M; Pelletier J
    Nucleic Acids Res; 1997 Nov; 25(21):4314-22. PubMed ID: 9336463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.